Skip to main content

News

Stay up-to-date on the latest medical news—from the most current FDA-approved drugs to the latest statistics on chronic conditions.

SingleCare stats Coronavirus FDA approvals FDA Seasonal Mental health Vaccines Diabetes

Most Recent

FDA Approval Stamp - Wezlana

FDA approves Wezlana

This medication is a biosimilar—like a generic for biologic medications—for the popular drug Stelara
Nov. 6, 2023
FDA approval stamp - Januvia

FDA approves Zituvio for diabetes

This new medication joins Januvia and Janumet on the market
Oct. 30, 2023
Statistical charts on a clipboard: Breast cancer statistics

Breast cancer statistics 2024

Breast cancer accounts for almost 30% of new female cancers each year. Learn more here.
Updated on Mar. 18, 2024
Clipboard holding sheet with charts: Cancer statistics

Cancer statistics 2024

Breast cancer is the most common type of cancer in the U.S.
Updated on Jan. 24, 2024
Three smartphones showing graphs and charts: Weight loss statistics

Weight loss statistics 2024

One-third of people living in the U.S. have obesity, and 50-70% wish to engage in a weight loss program
Updated on Jan. 24, 2024
Over-the-counter birth control FDA approved

FDA approves OTC birth control pills

This historic approval of Opill could expand contraceptive access to millions of people
Jul. 14, 2023
Clipboard holding graphs: Pregnancy statistics 2023

Pregnancy statistics 2024

Pregnancy is a very common occurrence and results in around 140 million babies born around the globe each year
Updated on Jan. 24, 2024
FDA approval - fezolinetant

New Rx approved for hot flashes

This medication can treat a symptom that affects roughly 80% of menopausal women in the U.S.
May 18, 2023
Smart phones with charts: Health insurance stats

Health insurance statistics 2024

The cost of health insurance will depend on the area in which a person lives, their age, and any pre-existing conditions
Updated on Jan. 24, 2024
A stamp for FDA approval - naloxone OTC

FDA approves OTC Narcan

This life-saving medication will be available without a prescription by late summer 2023
Mar. 31, 2023
FDA approval - fezolinetant

FDA approves migraine med

Zavzpret (zavegepant) is a new fast-acting treatment option
Mar. 17, 2023
1 2 3 4 … 17